Last reviewed · How we verify
Diet A group
At a glance
| Generic name | Diet A group |
|---|---|
| Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares (NA)
- The Effect of the DASH Diet on Treatment Outcomes in Adults Diagnosed With Rheumatoid Arthritis (NA)
- The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics (NA)
- Building Access to Food Through Systems and Solidarity (NA)
- Toddler Biomarker of Nutrition Study (NA)
- Dietary Intervention on Atopy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diet A group CI brief — competitive landscape report
- Diet A group updates RSS · CI watch RSS
- Daewoong Pharmaceutical Co. LTD. portfolio CI